Zobrazeno 1 - 10 of 207 pro vyhledávání: '"Yu VWC"'
1
Akademický článek
CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease.
Autor: Sharma A; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Boelens JJ; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Cancio M; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Hankins JS; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Bhad P; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Azizy M; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Lewandowski A; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Zhao X; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Chitnis S; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Peddinti R; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Zheng Y; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Kapoor N; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Ciceri F; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Maclachlan T; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Yang Y; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Liu Y; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Yuan J; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Naumann U; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Yu VWC; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., Stevenson SC; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., De Vita S; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.)., LaBelle JL; From St. Jude Children's Research Hospital, Memphis, TN (A.S., J.S.H., Y.Z.); Memorial Sloan Kettering Cancer Center, New York (J.-J.B., M.C.); the Novartis Institutes for BioMedical Research, Cambridge, MA (P.B., M.A., A.L., X.Z., S.C., T.M., Y.Y., Y.L., J.Y., V.W.C.Y., S.C.S., S.D.V.); University of Chicago Medicine, Chicago (R.P., J.L.L.); Children's Hospital Los Angeles, Los Angeles (N.K.); IRCCS San Raffaele Hospital, Milan (F.C.); and the Novartis Institutes for BioMedical Research, Basel, Switzerland (U.N.).
Publikováno v: The New England journal of medicine [N Engl J Med] 2023 Aug 31; Vol. 389 (9), pp. 820-832.
Zobrazit plný text záznamu
2
Akademický článek
Aldehyde dehydrogenase 3a2 protects AML cells from oxidative death and the synthetic lethality of ferroptosis inducers.
Autor: Yusuf RZ; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Department of Stem Cell and Regenerative Biology and.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA., Saez B; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Department of Stem Cell and Regenerative Biology and.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA., Sharda A; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Department of Stem Cell and Regenerative Biology and.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA., van Gastel N; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Department of Stem Cell and Regenerative Biology and.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA., Yu VWC; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Department of Stem Cell and Regenerative Biology and.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA., Baryawno N; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Department of Stem Cell and Regenerative Biology and.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA., Scadden EW; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Department of Stem Cell and Regenerative Biology and.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA., Acharya S; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Department of Stem Cell and Regenerative Biology and.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA., Chattophadhyay S; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA., Huang C; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA., Viswanathan V; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA., S'aulis D; Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE., Cobert J; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Department of Stem Cell and Regenerative Biology and.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA., Sykes DB; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Department of Stem Cell and Regenerative Biology and.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA., Keibler MA; Department of Chemical Engineering, MIT, Cambridge, MA., Das S; Department of Neurology, Massachusetts General Hospital, Boston, MA., Hutchinson JN; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA; and., Churchill M; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Department of Stem Cell and Regenerative Biology and.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA., Mukherjee S; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Department of Stem Cell and Regenerative Biology and.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA., Lee D; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Department of Stem Cell and Regenerative Biology and.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA., Mercier F; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Department of Stem Cell and Regenerative Biology and.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA., Doench J; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA., Bullinger L; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany., Logan DJ; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA., Schreiber S; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA., Stephanopoulos G; Department of Chemical Engineering, MIT, Cambridge, MA., Rizzo WB; Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE., Scadden DT; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Department of Stem Cell and Regenerative Biology and.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA.
Publikováno v: Blood [Blood] 2020 Sep 10; Vol. 136 (11), pp. 1303-1316.
Zobrazit plný text záznamu
3
Akademický článek
Genomic investigation of innate sensing pathways in the tumor microenvironment.
Autor: Quinn, Gabriella1 (AUTHOR), Maggiore, Gianna2 (AUTHOR), Li, Bo1,3,4,5,6 (AUTHOR) lib3@chop.edu
Publikováno v: BMC Cancer. 9/17/2024, Vol. 24 Issue 1, p1-13. 13p.
Zobrazit plný text záznamu
4
Akademický článek
Deficiency of SDHC promotes metastasis by reprogramming fatty acid metabolism in colorectal cancer.
Autor: Ding, Zhuoyu1 (AUTHOR), Wei, Yiyi1 (AUTHOR), Dai, Jingping1 (AUTHOR), Pan, Chaomin1 (AUTHOR), Yang, Li1 (AUTHOR), Li, Qingyuan1 (AUTHOR), Zhang, Yue1 (AUTHOR), Yan, Qun1 (AUTHOR), Wu, Changjie1 (AUTHOR), Li, Aimin1 (AUTHOR), Lan, Zhixian2 (AUTHOR) 15521132373@163.com, Liu, Side1,3 (AUTHOR) liuside2011@163.com, Wang, Xinke1 (AUTHOR) wangxk07@smu.edu.cn
Publikováno v: Journal of Translational Medicine. 8/7/2024, Vol. 22 Issue 1, p1-15. 15p.
Zobrazit plný text záznamu
5
Akademický článek
Recent progress of ferroptosis in cancers and drug discovery.
Autor: Xiang Wang1, Xinxin Ren2,3,4, Xu Lin5, Qi Li1, Yingqiong Zhang1, Jun Deng1, Binxin Chen1, Guoqing Ru2 15868197173@163.com, Ying Luo1 haoluoying@163.com, Nengming Lin1,6,7 lnm1013@zju.edu.cn
Publikováno v: Asian Journal of Pharmaceutical Sciences. Aug2024, Vol. 19 Issue 4, p1-21. 21p.
Zobrazit plný text záznamu
6
Akademický článek
TRIAMF: A New Method for Delivery of Cas9 Ribonucleoprotein Complex to Human Hematopoietic Stem Cells.
Autor: Yen J; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA., Fiorino M; NIBR Informatics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA., Liu Y; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA., Paula S; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA., Clarkson S; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA., Quinn L; Biotherapeutic and Analytical Tech, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA., Tschantz WR; Biotherapeutic and Analytical Tech, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA., Klock H; Biotherapeutics & Biotechnology, The Genomics Institute of the Novartis Research Foundation, La Jolla, California, USA., Guo N; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA., Russ C; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA., Yu VWC; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA., Mickanin C; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA., Stevenson SC; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA., Lee C; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA., Yang Y; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA. yi.yang@novartis.com.
Publikováno v: Scientific reports [Sci Rep] 2018 Nov 02; Vol. 8 (1), pp. 16304. Date of Electronic Publication: 2018 Nov 02.
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Epigenetic Memory Underlies Cell-Autonomous Heterogeneous Behavior of Hematopoietic Stem Cells.
Autor: Yu VWC; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA., Yusuf RZ; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA., Oki T; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA., Wu J; Broad Institute of Harvard and MIT, Cambridge, MA 02138, USA., Saez B; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA., Wang X; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA., Cook C; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA., Baryawno N; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA., Ziller MJ; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02138, USA., Lee E; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA; Division of Genetics, Brigham and Women's Hospital, Boston, MA 02115, USA., Gu H; Broad Institute of Harvard and MIT, Cambridge, MA 02138, USA., Meissner A; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02138, USA., Lin CP; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA., Kharchenko PV; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA. Electronic address: peter.kharchenko@post.harvard.edu., Scadden DT; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA. Electronic address: david_scadden@harvard.edu.
Publikováno v: Cell [Cell] 2016 Nov 17; Vol. 167 (5), pp. 1310-1322.e17.
Zobrazit plný text záznamu
10
Akademický článek
Leading Edge Techniques in the Quest for Characterizing Rare Hematopoietic Stem Cells.
Autor: Patel, Sweta B., Franceski, Alana M., Crown, Brittany L., Welner, Robert S.
Publikováno v: Current Stem Cell Reports; Dec2024, Vol. 10 Issue 4, p108-125, 18p
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje